文献速递血栓与止血

极高龄原发性免疫性血小板减少症患者:表现与管理的特殊性——来自前瞻性CARMEN-France登记研究的结果

Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry.
PubMed 文献 · Br J Haematol · 2021-11-05

基于前瞻性CARMEN-France登记研究,比较87例极高龄(≥80岁)与97例老年(65-79岁)原发免疫性血小板减少症(ITP)患者。极高龄组合并症更多(67.4% vs 47.9%),严重出血有更多趋势(10.3% vs 4.1%,P=0.1)。极高龄组中女性(OR 4.75)和血小板<20×10^9/L(OR 10.05)与出血相关,抗凝暴露与严重出血强相关(OR 7.61)。

要点

  • 极高龄ITP患者合并症更多(67.4% vs 47.9%),严重出血有更多趋势(10.3% vs 4.1%,P=0.1)。
  • 极高龄组中女性(OR 4.75)和血小板<20×10^9/L(OR 10.05)与出血相关。
  • 极高龄组中抗凝暴露与严重出血强相关(OR 7.61)。

核心结论

  • 极高龄ITP患者合并症更频繁,严重出血和死亡有更多趋势,但ITP药物暴露、一线治疗反应、二线治疗需求、持续性病程、出血、感染和血栓发生率与老年患者无差异。

研究设计与样本

  • 前瞻性CARMEN-France登记研究,纳入2013年至2018年间541例患者中的184例,其中极高龄组(≥80岁)87例,老年组(65-79岁)97例。

主要发现

  • 极高龄组平均年龄85.7岁,合并症更频繁(67.4% vs 47.9%)。
  • ITP起病时中位血小板计数两组相似,但极高龄组严重出血有更多趋势(10.3% vs 4.1%,P=0.1),死亡亦有更多趋势。
  • 极高龄组中与出血相关的因素为女性(OR 4.75,95%CI 1.31-17.32)和血小板计数<20×10^9/L(OR 10.05,95%CI 4.83-67.39)。
  • 极高龄组中抗凝暴露与严重出血强相关(OR 7.61,95%CI 1.77-32.83)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Data about the presentation and the management of primary immune thrombocytopenia (ITP) in very elderly patients (VEPs; aged ≥80 years) are lacking. The aim of the present study was to describe ITP in this subgroup. The data source was the prospective CARMEN-France registry. Patients included between 2013 and 2018 were selected. ITP presentation and management in VEPs was compared to elderly patients (EPs; aged 65-79 years). We assessed factors associated with bleeding at ITP onset in VEPs. Of 541 patients, 184 were included: 87 in the VEP group and 97 in the EP group. The mean age was 85·7 years in the VEP group. Comorbidities were more frequent in the VEP group (67·4% vs. 47·9%). The median platelet count at ITP onset was similar but severe bleeding tended to be more frequent in VEPs (10·3% vs. 4·1%, P = 0·1) as well as mortality. Exposure to ITP drugs, response to first-line treatment, need of second-line treatment, evolution towards persistency, occurrence of bleeding, infection and thrombosis did not differ between groups. In VEPs, factors associated to bleeding were female sex [odds ratio (OR) 4·75, 95% confidence interval (CI) 1·31-17·32] and platelet count of <20 × 109 /l (OR 10·05, 95% CI 4·83-67·39). Exposure to anticoagulants was strongly associated with severe bleeding (OR 7·61, 95% CI 1·77-32·83).

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Sokal A, de Nadaï T, Maquet J, et al. Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry. Br J Haematol. 2021. PMID: 34738634. doi:10.1111/bjh.17935

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。